Intravenous immune globulin in lysinuric protein intolerance.
In: Journal of inherited metabolic disease, Jg. 21 (1998-04-01), Heft 2, S. 95-102
Online
academicJournal
Zugriff:
In addition to systemic manifestations with skeletal, pulmonary, renal, and haematological signs, lysinuric protein intolerance (LPI), a membrane transport defect of cationic amino acids, is often complicated by severe life-threatening immunological manifestations. A 10-year-old boy with LPI who exhibited a severe systemic immunohaematological disease is described here. This patient showed cutaneous lesions similar to the subacute form of systemic lupus erythematosus, severe anaemia and dysproteinaemia, and a marked reduction of circulating T lymphocytes, mainly the CD4+ cells. In vitro bone marrow cell culture studies showed that addition of patient's serum induced macrophage proliferation and inhibited erythroid progenitor cell growth. Treatment with high-dose intravenous immune globulin resolved most of the clinical and laboratory abnormalities.
Titel: |
Intravenous immune globulin in lysinuric protein intolerance.
|
---|---|
Autor/in / Beteiligte Person: | Dionisi-Vici, C ; De Felice, L ; el Hachem M ; Bottero, S ; Rizzo, C ; Paoloni, A ; Goffredo, B ; Sabetta, G ; Caniglia, M |
Link: | |
Zeitschrift: | Journal of inherited metabolic disease, Jg. 21 (1998-04-01), Heft 2, S. 95-102 |
Veröffentlichung: | 2019- : [Hoboken, NJ] : Wiley ; <i>Original Publication</i>: [Lancaster, Eng.] MTP Press., 1998 |
Medientyp: | academicJournal |
ISSN: | 0141-8955 (print) |
DOI: | 10.1023/a:1005383307100 |
Schlagwort: |
|
Sonstiges: |
|